| Authors: |
Stanley CE Jr; Institute for Neurodegenerative Disorders, New Haven, CT., Fabrizio K; Institute for Neurodegenerative Disorders, New Haven, CT., McMahon BA; Institute for Neurodegenerative Disorders, New Haven, CT., Matthews-McGee A; Institute for Neurodegenerative Disorders, New Haven, CT., Fitzgerald C; Institute for Neurodegenerative Disorders, New Haven, CT., Singh Z; Institute for Neurodegenerative Disorders, New Haven, CT., Rigby NH; Institute for Neurodegenerative Disorders, New Haven, CT., Talarico JM; Institute for Neurodegenerative Disorders, New Haven, CT., Brown EG; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA., Korell M; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA., McGuire Kuhl M; The Michael J. Fox Foundation for Parkinson's Research, New York, NY., Destro C; The Michael J. Fox Foundation for Parkinson's Research, New York, NY., Pavese N; Clinical Ageing Research Unit, Newcastle University, Newcastle, UK., Garrido A; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain., Mollenhauer B; Department of Neurology, University Medical Center, Kassel, Germany., Chowdhury S; The Michael J. Fox Foundation for Parkinson's Research, New York, NY., Marek K; Institute for Neurodegenerative Disorders, New Haven, CT., Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA., Tropea TF; Institute for Neurodegenerative Disorders, New Haven, CT.; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. |
